Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Ionis Pharmaceuticals Inc...

    NASDAQ: IONS · Real-Time Price · USD
    35.26
    0.15 (0.43%)
    At close: Jun 05, 2025, 3:59 PM
    35.24
    -0.06%
    After-hours: Jun 05, 2025, 04:41 PM EDT

    Ionis Pharmaceuticals Statistics

    Share Statistics

    Ionis Pharmaceuticals has 159.16M shares outstanding. The number of shares has increased by 8.91% in one year.

    Shares Outstanding

    n/a
    		 159.16M

    Shares Change (YoY)

    n/a
    		 8.91%

    Shares Change (QoQ)

    n/a
    		 0.68%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 42

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 15.27M, so 9.6% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 15.27M

    Short % of Shares Out

    n/a
    		 9.6%

    Short % of Float

    n/a
    		 11.2%

    Short Ratio (days to cover)

    n/a
    		 9.36

    Valuation Ratios

    The PE ratio is -11.52 and the forward PE ratio is -11.33. Ionis Pharmaceuticals's PEG ratio is -0.61.

    PE Ratio

    n/a
    		 -11.52

    Forward PE

    n/a
    		 -11.33

    PS Ratio

    n/a
    		 7.41

    Forward PS

    n/a
    		 2.5

    PB Ratio

    n/a
    		 8.88

    P/FCF Ratio

    n/a
    		 -9.57

    PEG Ratio

    n/a
    		 -0.61
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Ionis Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 8.47, with a Debt / Equity ratio of 2.41.

    Current Ratio

    n/a
    		 8.47

    Quick Ratio

    n/a
    		 8.43

    Debt / Equity

    n/a
    		 2.41

    Debt / EBITDA

    n/a
    		 -2.98

    Debt / FCF

    n/a
    		 -2.59

    Interest Coverage

    n/a
    		 -5.25

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $659,623.95

    Profits Per Employee

    n/a
    		 $-424,599.63

    Employee Count

    n/a
    		 1,069

    Asset Turnover

    n/a
    		 0.23

    Inventory Turnover

    n/a
    		 0.9

    Taxes

    Income Tax

    n/a
    		 -6.17M

    Effective Tax Rate

    n/a
    		 1.34%

    Stock Price Statistics

    The stock price has increased by -11.34% in the last 52 weeks. The beta is 0.18, so Ionis Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.18

    52-Week Price Change

    n/a
    		 -11.34%

    50-Day Moving Average

    n/a
    		 31.04

    200-Day Moving Average

    n/a
    		 35.7

    Relative Strength Index (RSI)

    n/a
    		 64.39

    Average Volume (20 Days)

    n/a
    		 1,670,436

    Income Statement

    In the last 12 months, Ionis Pharmaceuticals had revenue of 705.14M and earned -453.9M in profits. Earnings per share was -3.04.

    Revenue

    n/a
    		 705.14M

    Gross Profit

    n/a
    		 693.92M

    Operating Income

    n/a
    		 -475.08M

    Net Income

    n/a
    		 -453.9M

    EBITDA

    n/a
    		 -475.08M

    EBIT

    n/a
    		 -477.06M

    Earnings Per Share (EPS)

    n/a
    		 -3.04
    Full Income Statement

    Balance Sheet

    The company has 242.08M in cash and 1.42B in debt, giving a net cash position of -1.17B.

    Cash & Cash Equivalents

    n/a
    		 242.08M

    Total Debt

    n/a
    		 1.42B

    Net Cash

    n/a
    		 -1.17B

    Retained Earnings

    n/a
    		 -2.25B

    Total Assets

    n/a
    		 2.81B

    Working Capital

    n/a
    		 2.17B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -500.95M and capital expenditures -45.28M, giving a free cash flow of -546.23M.

    Operating Cash Flow

    n/a
    		 -500.95M

    Capital Expenditures

    n/a
    		 -45.28M

    Free Cash Flow

    n/a
    		 -546.23M

    FCF Per Share

    n/a
    		 -3.65
    Full Cash Flow Statement

    Margins

    Gross margin is 98.41%, with operating and profit margins of -67.37% and -64.37%.

    Gross Margin

    n/a
    		 98.41%

    Operating Margin

    n/a
    		 -67.37%

    Pretax Margin

    n/a
    		 -65.25%

    Profit Margin

    n/a
    		 -64.37%

    EBITDA Margin

    n/a
    		 -67.37%

    EBIT Margin

    n/a
    		 -67.37%

    FCF Margin

    n/a
    		 -77.46%

    Dividends & Yields

    IONS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for IONS is $59, which is 66.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $59

    Price Target Difference

    n/a
    		 66.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 18
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.82

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist